aluates Reports

$ 0.0

Automative

Global Urology Drugs Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-6T8081

Global Urology Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Urology Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-6T8081

Report

September 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Urology Drugs Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Urology Drugs Market

Urology drugs used in the treatment of urogenital conditions and diseases.

The global Urology Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:

This report presents an overview of global market for Urology Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Urology Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Urology Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urology Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Urology Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Urology Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Urology Drugs Market Report

Report Metric	Details
Report Name	Urology Drugs Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Α (alpha) Blockers 5 α-reductase Inhibitors
Segment by Application	Hospital Clinic Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GP Pharm, Tolmar
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urology Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Urology Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urology Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urology Drugs Market report?

Ans: The main players in the Urology Drugs Market are GP Pharm, Tolmar

What are the Application segmentation covered in the Urology Drugs Market report?

Ans: The Applications covered in the Urology Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Urology Drugs Market report?

Ans: The Types covered in the Urology Drugs Market report are Α (alpha) Blockers, 5 α-reductase Inhibitors

1 Study Coverage

1.1 Urology Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Urology Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Α (alpha) Blockers

1.2.3 5 α-reductase Inhibitors

1.3 Market by Application

1.3.1 Global Urology Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Urology Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Urology Drugs Revenue by Region

2.2.1 Global Urology Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Urology Drugs Revenue by Region (2019-2024)

2.2.3 Global Urology Drugs Revenue by Region (2025-2030)

2.2.4 Global Urology Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Urology Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Urology Drugs Sales by Region

2.4.1 Global Urology Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Urology Drugs Sales by Region (2019-2024)

2.4.3 Global Urology Drugs Sales by Region (2025-2030)

2.4.4 Global Urology Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Urology Drugs Sales by Manufacturers

3.1.1 Global Urology Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Urology Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urology Drugs in 2023

3.2 Global Urology Drugs Revenue by Manufacturers

3.2.1 Global Urology Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Urology Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Urology Drugs Revenue in 2023

3.3 Global Key Players of Urology Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Urology Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Urology Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Urology Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Urology Drugs Sales by Type

4.1.1 Global Urology Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Urology Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Urology Drugs Sales Market Share by Type (2019-2030)

4.2 Global Urology Drugs Revenue by Type

4.2.1 Global Urology Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Urology Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Urology Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Urology Drugs Price by Type

4.3.1 Global Urology Drugs Price by Type (2019-2024)

4.3.2 Global Urology Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Urology Drugs Sales by Application

5.1.1 Global Urology Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Urology Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Urology Drugs Sales Market Share by Application (2019-2030)

5.2 Global Urology Drugs Revenue by Application

5.2.1 Global Urology Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Urology Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Urology Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Urology Drugs Price by Application

5.3.1 Global Urology Drugs Price by Application (2019-2024)

5.3.2 Global Urology Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Urology Drugs Market Size by Type

6.1.1 US & Canada Urology Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Urology Drugs Revenue by Type (2019-2030)

6.2 US & Canada Urology Drugs Market Size by Application

6.2.1 US & Canada Urology Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Urology Drugs Revenue by Application (2019-2030)

6.3 US & Canada Urology Drugs Market Size by Country

6.3.1 US & Canada Urology Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Urology Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Urology Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Urology Drugs Market Size by Type

7.1.1 Europe Urology Drugs Sales by Type (2019-2030)

7.1.2 Europe Urology Drugs Revenue by Type (2019-2030)

7.2 Europe Urology Drugs Market Size by Application

7.2.1 Europe Urology Drugs Sales by Application (2019-2030)

7.2.2 Europe Urology Drugs Revenue by Application (2019-2030)

7.3 Europe Urology Drugs Market Size by Country

7.3.1 Europe Urology Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Urology Drugs Sales by Country (2019-2030)

7.3.3 Europe Urology Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Urology Drugs Market Size

8.1.1 China Urology Drugs Sales (2019-2030)

8.1.2 China Urology Drugs Revenue (2019-2030)

8.2 China Urology Drugs Market Size by Application

8.2.1 China Urology Drugs Sales by Application (2019-2030)

8.2.2 China Urology Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Urology Drugs Market Size by Type

9.1.1 Asia Urology Drugs Sales by Type (2019-2030)

9.1.2 Asia Urology Drugs Revenue by Type (2019-2030)

9.2 Asia Urology Drugs Market Size by Application

9.2.1 Asia Urology Drugs Sales by Application (2019-2030)

9.2.2 Asia Urology Drugs Revenue by Application (2019-2030)

9.3 Asia Urology Drugs Sales by Region

9.3.1 Asia Urology Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Urology Drugs Revenue by Region (2019-2030)

9.3.3 Asia Urology Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Urology Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Urology Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Urology Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Urology Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Urology Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Urology Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Urology Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Urology Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Urology Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Urology Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Astellas

11.1.1 Astellas Company Information

11.1.2 Astellas Overview

11.1.3 Astellas Urology Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Astellas Recent Developments

11.2 Endo

11.2.1 Endo Company Information

11.2.2 Endo Overview

11.2.3 Endo Urology Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Endo Recent Developments

11.3 GP Pharm

11.3.1 GP Pharm Company Information

11.3.2 GP Pharm Overview

11.3.3 GP Pharm Urology Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GP Pharm Recent Developments

11.4 Tolmar

11.4.1 Tolmar Company Information

11.4.2 Tolmar Overview

11.4.3 Tolmar Urology Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Tolmar Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Urology Drugs Industry Chain Analysis

12.2 Urology Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Urology Drugs Production Mode & Process

12.4 Urology Drugs Sales and Marketing

12.4.1 Urology Drugs Sales Channels

12.4.2 Urology Drugs Distributors

12.5 Urology Drugs Customers

13 Market Dynamics

13.1 Urology Drugs Industry Trends

13.2 Urology Drugs Market Drivers

13.3 Urology Drugs Market Challenges

13.4 Urology Drugs Market Restraints

14 Key Findings in The Global Urology Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Urology Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Α (alpha) Blockers

Table 3. Major Manufacturers of 5 α-reductase Inhibitors

Table 4. Global Urology Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Urology Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Urology Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Urology Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Urology Drugs Revenue Market Share by Region (2019-2024)

Table 9. Global Urology Drugs Revenue Market Share by Region (2025-2030)

Table 10. Global Urology Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Urology Drugs Sales by Region (2019-2024) & (MT)

Table 12. Global Urology Drugs Sales by Region (2025-2030) & (MT)

Table 13. Global Urology Drugs Sales Market Share by Region (2019-2024)

Table 14. Global Urology Drugs Sales Market Share by Region (2025-2030)

Table 15. Global Urology Drugs Sales by Manufacturers (2019-2024) & (MT)

Table 16. Global Urology Drugs Sales Share by Manufacturers (2019-2024)

Table 17. Global Urology Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Urology Drugs Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Urology Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Urology Drugs Price by Manufacturers 2019-2024 (USD/Kg)

Table 21. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2023)

Table 23. Global Key Manufacturers of Urology Drugs, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Urology Drugs, Product Offered and Application

Table 25. Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Urology Drugs Sales by Type (2019-2024) & (MT)

Table 28. Global Urology Drugs Sales by Type (2025-2030) & (MT)

Table 29. Global Urology Drugs Sales Share by Type (2019-2024)

Table 30. Global Urology Drugs Sales Share by Type (2025-2030)

Table 31. Global Urology Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Urology Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Urology Drugs Revenue Share by Type (2019-2024)

Table 34. Global Urology Drugs Revenue Share by Type (2025-2030)

Table 35. Urology Drugs Price by Type (2019-2024) & (USD/Kg)

Table 36. Global Urology Drugs Price Forecast by Type (2025-2030) & (USD/Kg)

Table 37. Global Urology Drugs Sales by Application (2019-2024) & (MT)

Table 38. Global Urology Drugs Sales by Application (2025-2030) & (MT)

Table 39. Global Urology Drugs Sales Share by Application (2019-2024)

Table 40. Global Urology Drugs Sales Share by Application (2025-2030)

Table 41. Global Urology Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Urology Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Urology Drugs Revenue Share by Application (2019-2024)

Table 44. Global Urology Drugs Revenue Share by Application (2025-2030)

Table 45. Urology Drugs Price by Application (2019-2024) & (USD/Kg)

Table 46. Global Urology Drugs Price Forecast by Application (2025-2030) & (USD/Kg)

Table 47. US & Canada Urology Drugs Sales by Type (2019-2024) & (MT)

Table 48. US & Canada Urology Drugs Sales by Type (2025-2030) & (MT)

Table 49. US & Canada Urology Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Urology Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Urology Drugs Sales by Application (2019-2024) & (MT)

Table 52. US & Canada Urology Drugs Sales by Application (2025-2030) & (MT)

Table 53. US & Canada Urology Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Urology Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Urology Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Urology Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Urology Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Urology Drugs Sales by Country (2019-2024) & (MT)

Table 59. US & Canada Urology Drugs Sales by Country (2025-2030) & (MT)

Table 60. Europe Urology Drugs Sales by Type (2019-2024) & (MT)

Table 61. Europe Urology Drugs Sales by Type (2025-2030) & (MT)

Table 62. Europe Urology Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Urology Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Urology Drugs Sales by Application (2019-2024) & (MT)

Table 65. Europe Urology Drugs Sales by Application (2025-2030) & (MT)

Table 66. Europe Urology Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Urology Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Urology Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Urology Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Urology Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Urology Drugs Sales by Country (2019-2024) & (MT)

Table 72. Europe Urology Drugs Sales by Country (2025-2030) & (MT)

Table 73. China Urology Drugs Sales by Type (2019-2024) & (MT)

Table 74. China Urology Drugs Sales by Type (2025-2030) & (MT)

Table 75. China Urology Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Urology Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Urology Drugs Sales by Application (2019-2024) & (MT)

Table 78. China Urology Drugs Sales by Application (2025-2030) & (MT)

Table 79. China Urology Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Urology Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Urology Drugs Sales by Type (2019-2024) & (MT)

Table 82. Asia Urology Drugs Sales by Type (2025-2030) & (MT)

Table 83. Asia Urology Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Urology Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Urology Drugs Sales by Application (2019-2024) & (MT)

Table 86. Asia Urology Drugs Sales by Application (2025-2030) & (MT)

Table 87. Asia Urology Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Urology Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Urology Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Urology Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Urology Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Urology Drugs Sales by Region (2019-2024) & (MT)

Table 93. Asia Urology Drugs Sales by Region (2025-2030) & (MT)

Table 94. Middle East, Africa and Latin America Urology Drugs Sales by Type (2019-2024) & (MT)

Table 95. Middle East, Africa and Latin America Urology Drugs Sales by Type (2025-2030) & (MT)

Table 96. Middle East, Africa and Latin America Urology Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Urology Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Urology Drugs Sales by Application (2019-2024) & (MT)

Table 99. Middle East, Africa and Latin America Urology Drugs Sales by Application (2025-2030) & (MT)

Table 100. Middle East, Africa and Latin America Urology Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Urology Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Urology Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Urology Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Urology Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Urology Drugs Sales by Country (2019-2024) & (MT)

Table 106. Middle East, Africa and Latin America Urology Drugs Sales by Country (2025-2030) & (MT)

Table 107. Astellas Company Information

Table 108. Astellas Description and Major Businesses

Table 109. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 110. Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Astellas Recent Developments

Table 112. Endo Company Information

Table 113. Endo Description and Major Businesses

Table 114. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 115. Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Endo Recent Developments

Table 117. GP Pharm Company Information

Table 118. GP Pharm Description and Major Businesses

Table 119. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 120. GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. GP Pharm Recent Developments

Table 122. Tolmar Company Information

Table 123. Tolmar Description and Major Businesses

Table 124. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 125. Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Tolmar Recent Developments

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Urology Drugs Distributors List

Table 130. Urology Drugs Customers List

Table 131. Urology Drugs Market Trends

Table 132. Urology Drugs Market Drivers

Table 133. Urology Drugs Market Challenges

Table 134. Urology Drugs Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Urology Drugs Product Picture

Figure 2. Global Urology Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Urology Drugs Market Share by Type in 2023 & 2030

Figure 4. Α (alpha) Blockers Product Picture

Figure 5. 5 α-reductase Inhibitors Product Picture

Figure 6. Global Urology Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Urology Drugs Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Urology Drugs Report Years Considered

Figure 12. Global Urology Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Urology Drugs Revenue 2019-2030 (US$ Million)

Figure 14. Global Urology Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Urology Drugs Revenue Market Share by Region (2019-2030)

Figure 16. Global Urology Drugs Sales 2019-2030 ((MT)

Figure 17. Global Urology Drugs Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Urology Drugs Sales YoY (2019-2030) & (MT)

Figure 19. US & Canada Urology Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Urology Drugs Sales YoY (2019-2030) & (MT)

Figure 21. Europe Urology Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Urology Drugs Sales YoY (2019-2030) & (MT)

Figure 23. China Urology Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Urology Drugs Sales YoY (2019-2030) & (MT)

Figure 25. Asia (excluding China) Urology Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Urology Drugs Sales YoY (2019-2030) & (MT)

Figure 27. Middle East, Africa and Latin America Urology Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Urology Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Urology Drugs in the World: Market Share by Urology Drugs Revenue in 2023

Figure 30. Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Urology Drugs Sales Market Share by Type (2019-2030)

Figure 32. Global Urology Drugs Revenue Market Share by Type (2019-2030)

Figure 33. Global Urology Drugs Sales Market Share by Application (2019-2030)

Figure 34. Global Urology Drugs Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Urology Drugs Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Urology Drugs Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Urology Drugs Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Urology Drugs Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Urology Drugs Revenue Share by Country (2019-2030)

Figure 40. US & Canada Urology Drugs Sales Share by Country (2019-2030)

Figure 41. U.S. Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Urology Drugs Sales Market Share by Type (2019-2030)

Figure 44. Europe Urology Drugs Revenue Market Share by Type (2019-2030)

Figure 45. Europe Urology Drugs Sales Market Share by Application (2019-2030)

Figure 46. Europe Urology Drugs Revenue Market Share by Application (2019-2030)

Figure 47. Europe Urology Drugs Revenue Share by Country (2019-2030)

Figure 48. Europe Urology Drugs Sales Share by Country (2019-2030)

Figure 49. Germany Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 50. France Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. China Urology Drugs Sales Market Share by Type (2019-2030)

Figure 55. China Urology Drugs Revenue Market Share by Type (2019-2030)

Figure 56. China Urology Drugs Sales Market Share by Application (2019-2030)

Figure 57. China Urology Drugs Revenue Market Share by Application (2019-2030)

Figure 58. Asia Urology Drugs Sales Market Share by Type (2019-2030)

Figure 59. Asia Urology Drugs Revenue Market Share by Type (2019-2030)

Figure 60. Asia Urology Drugs Sales Market Share by Application (2019-2030)

Figure 61. Asia Urology Drugs Revenue Market Share by Application (2019-2030)

Figure 62. Asia Urology Drugs Revenue Share by Region (2019-2030)

Figure 63. Asia Urology Drugs Sales Share by Region (2019-2030)

Figure 64. Japan Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. India Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Urology Drugs Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Urology Drugs Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Urology Drugs Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Urology Drugs Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Urology Drugs Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Urology Drugs Sales Share by Country (2019-2030)

Figure 75. Brazil Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Urology Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. Urology Drugs Value Chain

Figure 81. Urology Drugs Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Urological Cancer Drugs Market Research Report 2024

Global Urological Cancer Therapeutics Drugs Market Research Report 2024

Global Urological Surgery Laser Market Insights Forecast to 2030

Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Urology Surgery Laser Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Medicine Market Insights Forecast to 2030

Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary Products Market Research Report 2025

Genitourinary Cancers Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary Tract Cancer Treatment Market Research Report 2024

Urology Medical Laser Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Urological Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Genitourinary System Treatment Market Research Report 2024

Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urological Operating Tables Market Insights Forecast to 2030

Global Urinary Tract Infection Therapeutics Market Research Report 2025

Global Urinary Incontinence Drug Market Research Report 2025

Global Urinary Tract Infection UTI Medications Market Research Report 2025

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-16160

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-10G2665

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »